Insider · CIK 0001286642

ALBRECHT DETLEF

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001286642

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+190K sh	—	—	190,000
2020-12-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+80K sh	—	—	80,000
2020-09-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−1,000 sh	$22.21	−$22.2K	20,212
2020-09-01	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)S Sale	Chief Medical Officer	SSale	−1,000 sh	—	—	67,468
2020-09-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	$4.56	+$4,560	21,212
2020-08-03	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−200 sh	$23.12	−$4,624.02	20,212
2020-08-03	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+800 sh	$4.56	+$3,648	21,012
2020-08-03	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−800 sh	$22.85	−$18.3K	20,212
2020-08-03	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+200 sh	$4.56	+$912	20,412
2020-08-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)S Sale	Chief Medical Officer	SSale	−1,000 sh	—	—	68,468
2020-07-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+100 sh	$4.56	+$456	20,312
2020-07-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+300 sh	$4.56	+$1,368	20,512
2020-07-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−300 sh	$25.69	−$7,707.33	20,212
2020-07-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+600 sh	$4.56	+$2,736	20,812
2020-07-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−600 sh	$26.99	−$16.2K	20,212
2020-07-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−100 sh	$27.81	−$2,781	20,212
2020-07-01	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)S Sale	Chief Medical Officer	SSale	−1,000 sh	—	—	69,468
2020-06-01	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)S Sale	Chief Medical Officer	SSale	−1,000 sh	—	—	70,468
2020-06-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−1,000 sh	$25.26	−$25.3K	20,212
2020-06-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	$4.56	+$4,560	21,212
2020-05-05	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)S Sale	Chief Medical Officer	SSale	−1,000 sh	—	—	71,468
2020-05-05	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−1,000 sh	$20.00	−$20K	20,212
2020-05-05	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	$4.56	+$4,560	21,212
2020-04-14	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+800 sh	$4.56	+$3,648	21,012
2020-04-14	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)S Sale	Chief Medical Officer	SSale	−800 sh	—	—	72,468
2020-04-14	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)S Sale	Chief Medical Officer	SSale	−800 sh	—	—	72,468
2020-04-14	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+800 sh	$4.56	+$3,648	20,812
2020-04-14	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−800 sh	$20.00	−$16K	20,012
2020-04-14	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−800 sh	$20.00	−$16K	20,212
2020-04-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+200 sh	$4.56	+$912	20,412
2020-04-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−200 sh	$20.25	−$4,049	20,012
2020-04-01	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)S Sale	Chief Medical Officer	SSale	−200 sh	—	—	73,268
2020-04-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+200 sh	$4.56	+$912	20,412
2020-04-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−200 sh	$20.25	−$4,049	20,212
2020-04-01	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)S Sale	Chief Medical Officer	SSale	−200 sh	—	—	73,268
2020-03-11	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	$4.56	+$4,560	21,212
2020-03-11	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	—	—	73,468
2020-03-11	Satsuma Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−1,000 sh	$27.42	−$27.4K	20,212
2020-03-04	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+60K sh	—	—	60,000
2004-04-12	Ardea Biosciences, Inc./DECommon Stock (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+210K sh	—	—	210,000

Recent filings

Accepted (ET)
Jun 74
ALBRECHT DETLEF0001567619-22-012478
SEC(opens sec.gov)
Dec 74
ALBRECHT DETLEF0001567619-20-020716
SEC(opens sec.gov)
Sep 34
ALBRECHT DETLEF0001567619-20-016413
SEC(opens sec.gov)
Aug 54
ALBRECHT DETLEF0001567619-20-014306
SEC(opens sec.gov)
Jul 24
ALBRECHT DETLEF0001567619-20-012818
SEC(opens sec.gov)
Jun 24
ALBRECHT DETLEF0001567619-20-011565
SEC(opens sec.gov)

Companies

Address

SATSUMA PHARMACEUTICALS, INC. 400 OYSTER POINT BOULEVARD, SUITE 221

SOUTH SAN FRANCISCO, CA, 94080